Morbid Obesity Clinical Trial
Official title:
Bariatric Surgery Plus Weight Watchers vs. Weight Watchers in Underserved Minorities: Randomized Controlled Cross-over Trial
Obesity is a costly multi-etiology world disease of fat storage. Morbid obesity is defines as greater than 100 pounds overweight and/or greater than 200 % of ideal body weight. Chronic underemployment, poor housing, child abuse, limited education, stress and anxiety are all associated with maternal morbid obesity. These latter conditions leave many patients in a state of economic, social and emotional poverty with need for life-long welfare support. For patients with true morbid obesity a standard surgical procedure is currently the procedure of choice especially among patients who fail standard medical intervention. The major procedures performed for morbid obesity include the Roux-en-Y gastric bypass, sleeve gastrectomy and laparoscopic band procedure. The sleeve gastrectomy is purely a restrictive procedure without malabsorptive components which involves one single staple line and can be performed laparoscopically in less than one hour. While these surgical procedures are recognized as "standard" procedures for patient who have failed medical treatment and are "covered" by most health plans, access to these procedures is limited for the medically underserved, rural, poor or underrepresented minorities since national, state and municipal health plans either provide minimal coverage or no coverage at all for surgery for morbid obesity. Reimbursement to providers offering these procedures is minimal and thus access to bariatric surgery is unlikely within a timely fashion.
Obesity is a costly multi-etiology world disease of fat storage. Morbid obesity is defined
as greater than 100 pounds overweight and/or greater than 200 % of ideal body weight. A
commonly used measure of body mass is the Body Mass Index, BMI, which is the weight in
kilograms divided by the body surface area in meters squared (kg/m²). A BMI greater than or
equal to 40 is defined as morbid obesity. Morbid obesity is associated with an
extraordinarily high increased risk of mortality principally from cardiovascular and
cerebrovascular diseases. Morbidly obese patients routinely develop early hypertension,
hypercholesterolemia, and diabetes mellitus. Currently, we estimate that approximately 15%
of the adult U.S. population is morbidly obese. Morbid obesity is certainly not solely a
disease of the economically advantaged. In developed countries where calories are readily
available and relatively inexpensive, morbid obesity is disproportionately noted in
culturally and economically disadvantaged people. Most disturbing, morbid obesity is
especially prevalent among lower socioeconomic women between the ages of 21-40 years, when
such women are bearing and rearing children. Morbid obesity for this patient population is
clearly associated with the "Metabolic Syndrome" including such documented medical
conditions such as diabetes, hypertension, sleep apnea, hypercholesterolemia and ultimately
early onset heart disease and chronic lung disease. In addition, chronic underemployment,
poor housing, child abuse, limited education, stress and anxiety are all associated with
maternal morbid obesity. These latter conditions leave many patients in a state of economic,
social and emotional poverty with need for life-long welfare support. The impact on the next
generation reared by these morbidly obese underserved minority patients is likely to be
dire.
Currently the major treatment programs available for morbid obesity including supervised
dietary programs, pre-planned meals, positive reinforcement, and even pharmacological
therapies are costly and have a very low permanent success rate. For patients with true
morbid obesity a standard surgical procedure is currently the procedure of choice especially
among patients who fail standard medical intervention.
One of the best known international programs is Weight Watchers International. Recent
studies have documented weight loss of greater to or equal to 5 kg over a 12 month period.
Weight Watchers is an international company based in the United States that offers various
products and services to assist weight loss and maintenance. It was founded in 1963 and
operates in about 30 countries world-wide. The Weight Watcher's philosophy is to use a
science-driven approach to help participants lose weight by forming helpful habits, eating
smarter, getting more exercise and providing support. Weight Watchers uses the PointPlus
System. This system is a calculation based on dietary protein, carbohydrates, fat and fiber.
The weekly program focuses on assisting members in creating a caloric deficit to lose
weight. The Weight Watchers Program is designed to result in a weight loss of ½ to 2 pounds
per week. Members of Weight Watchers will be expected to go to hourly weekly meetings for
selected topic discussions and to "weigh-in". Membership in the Weight Watchers Program
includes not only weekly meetings, but also access to the Weight Watchers online, access to
the Weight Watchers eTools and access to the Weight Watchers mobile applications.
Weekly Meeting Process:
For the half hour prior to start-times, the participant weighs in. Weight is recorded into a
computer to track the participant's progress. The topic of the week is announced (i.e. The
Sleep-Weight Loss Connection). The weekly topic is discussed amongst members and the
moderator (who is a Weight Watchers lifetime member) focuses on the relationship of the
topic to weight loss. All are encouraged to verbally participate but it is not a
requirement. The moderator rewards members who have reached certain goals. Members also
discuss their progress throughout the past week. At the end of the meeting, the moderator
enforces the adoption of life-style changes to incorporate the topic of the week into daily
life. Members are never pressured into buying informational products, but can do so if they
decide to.
The major procedures performed for morbid obesity include the Roux-en-Y gastric bypass,
sleeve gastrectomy and laparoscopic band procedure. The sleeve gastrectomy is a permanent
restrictive procedure without malabsorptive components which involves a single staple line
and can be performed laparoscopically in less than one hour.
While these surgical procedures are recognized as "standard" procedures for patient who have
failed medical treatment and are "covered" by most health plans, access to these procedures
is limited for the medically underserved, rural, poor or underrepresented minorities since
national, state and municipal health plans either provide minimal coverage or no coverage at
all for surgery for morbid obesity. Often, these patients wait years for elective bariatric
procedures. Reimbursement to providers offering these procedures is minimal and thus access
to bariatric surgery is unlikely within a timely fashion.
The laparoscopic sleeve gastrectomy involves the placement of 5 trocars. First, the V-shaped
liver suspension technique (V-LIST) is used to gain a broad operative view of the
gastroesophageal junction[11-12] and a silicone Penrose drain is inserted into the
peritoneal cavity and stapled to the pars condensa of the lesser omentum and parietal
peritoneum using 2-0 Prolene (Ethicon) for liver retraction. The left lobe of liver is
retracted with the V-shaped suspension technique. The greater curvature of stomach is freed
beginning from 6 cm proximal to the pylorus to the angle of His with the harmonic scalpel
(Ethicon). Care is taken to preserve the gastroepiploic vessels. A bougie (36-40 Fr) is
placed in the stomach against the lesser curvature to guide the stapling. Gastric resection
is performed with a stapler (Echelon 60, Ethicon) along a line parallel to the bougie
beginning from 6 cm proximal to the pylorus and extending to the cardia. The remnant stomach
is removed from the abdominal cavity by slightly enlarging the incision where the Versaport
cannula has been placed. A leak check may be performed at the same time by insufflating with
a gastroscope with the remnant gastric section submerged in irrigation fluid and by infusing
sterile methylene blue through a nasogastric tube. The staple line may also be oversewn (3-0
Vicryl, Ethicon), only along the bleeding and leakage areas, or areas with the potential for
such complications. A nasogastric decompression tube may be placed to monitor bleeding and
an intraperitoneal drain placed under an anastomotic stoma.
For the purposes of this study we will consider the following to meet the criteria of
populations that are underserved, rural, poor and/or underrepresented:
Medically Underserved Populations Populations that have inadequate access to, or reduced
utilization of, high-quality cancer prevention, screening and early detection, treatment,
and/or rehabilitation services. Included are rural, low-literacy, and low-income
populations. An effort to clarify and further define "medically underserved" is currently
underway at NIH.
Rural The working definition of rural, taken from the U.S. Census Bureau, is somewhat vague.
"Rural" is defined as territory, populations, and housing units not classified as "urban."
The Census Bureau's definition of "urban" is places of 2,500 or more persons incorporated as
cities, villages, boroughs, and towns.
Poor (Low Income)
The 1998 DHHS Poverty Guidelines (also referred to as the "Federal poverty level") define a
poverty threshold as an annual income of approximately $10,000 for a single individual and
an annual income of approximately $20,000 for a family of 4 (Federal Register 63, #36,
February 24, 1998, pp 9235-9238).
Underrepresented Minority
For NCI purposes, a person is an underrepresented minority if he or she belongs to a
minority group that is underrepresented in biomedical and behavioral science careers, based
on their minority group's representation in the total population. Using this definition and
available data on minority representation in the health professions, science, and
engineering, blacks, Hispanics, American Indian or Alaskan Native, and Pacific Islanders are
classified as underrepresented minorities. Asians are not considered to be an
underrepresented minority.
The bariatric surgical procedures, including the sleeve gastrectomy, performed at UCSF by
the principal investigator, Dr. Stanley J. Rogers, (Chief of Minimally Invasive Surgery and
Surgical Director of Bariatric Surgery) for the past 5 years, has a documented zero percent
mortality, a mean 98% laparoscopic completion rate and a mean duration of hospitalization
under 3 days. The cost of these procedures also is relatively inexpensive while requiring
less than 2 hours of surgery time.
We propose to randomize patients to a surgical arm (sleeve gastrectomy) plus the Weight
Watchers program or to the Weight Watchers program alone. We will employ extensive metrics
to assess the impact of laparoscopic sleeve gastrectomy surgery plus Weight Watchers vs.
Weight Watchers Program alone monitoring for 12 months the following:
Weight reduction efficacy Self-worth assessment Health care cost Economic productivity
Stress and anger Intergenerational impact
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03657927 -
A Comparison of McGrath MAC Versus C-MAC Videolaryngoscopes in Morbidly Obese Patients
|
N/A | |
Recruiting |
NCT04934826 -
Comparison of the Absorption of Hydrolyzed or Intact Proteins in Morbid Obese Patients After the Roux Y Gastric Bypass
|
N/A | |
Completed |
NCT03181347 -
The Microbiology of Bariatric Surgery
|
N/A | |
Completed |
NCT03886870 -
Obesity, Lifestyle and Work Intervention
|
N/A | |
Active, not recruiting |
NCT04433338 -
The PREBA Study: Effect of Preoperative Weight Loss With a 14-day Low-calorie Diet on Surgical Procedure and Outcomes in Patients Undergoing RYGB Surgery
|
N/A | |
Completed |
NCT03553849 -
Utilization of Very Low Calorie Diet in Obese General Surgery Patients
|
N/A | |
Completed |
NCT05854875 -
Diabetes Remission After RYGBP and RYGBP With Fundus Resection
|
N/A | |
Not yet recruiting |
NCT03203161 -
Registry on Obesity Surgery in Adolescents
|
||
Not yet recruiting |
NCT03601273 -
Bariatric Embolization Trial for the Obese Nonsurgical
|
Phase 1 | |
Recruiting |
NCT02129296 -
Intragastric Balloon, Air Versus Fluid Filled: Randomized Prospective Study
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT01564732 -
Multicenter Prospective Randomized Controlled Trial of Plicated Laparoscopic Adjustable Gastric Banding
|
N/A | |
Completed |
NCT02033265 -
Ultrasound-Guided Axillary Brachial Plexus Block: Influence of Obesity
|
||
Completed |
NCT01963637 -
Gastric Volumetry by Gastric Tomodensitometry With Gas
|
N/A | |
Not yet recruiting |
NCT01652105 -
Randomized Trial of Preoperative Diets Before Bariatric Surgery
|
N/A | |
Completed |
NCT01955993 -
Fentanyl Metabolism in Obese Adolescents
|
N/A | |
Completed |
NCT01149512 -
Outcomes of the Adjustable Gastric Band in a Publicly Funded Obesity Program
|
N/A | |
Terminated |
NCT01759550 -
Prospective Case-Series of Ligasure Advance Pistol Grip and LigaSure Blunt Tip
|
||
Recruiting |
NCT01685177 -
Single Anastomosis Duodeno-Ileal Bypass vs Standard Duodenal Switch as a Second Step After Sleeve Gastrectomy in the Super-Morbid Obese Patient
|
N/A | |
Completed |
NCT00624624 -
Follow-up of Serum Androgen Profile After Bariatric Surgery in Men With Obesity Related Hypogonadotropic Hypogonadism
|
N/A | |
Completed |
NCT01675713 -
Lifestyleintervention for the Treatment of Severe Obesity
|
N/A |